Treatment ofAcinetobacterInfections
Clinical Infectious Diseases2010Vol. 51(1), pp. 79–84
Citations Over TimeTop 10% of 2010 papers
Abstract
Acinetobacter baumannii remains an important and difficult-to-treat pathogen whose resistance patterns result in significant challenges for the clinician. Despite the prevalence and interest in A. baumannii infections, there is relatively limited well-controlled scientific data to help the clinician select optimal empirical and subsequent targeted therapy for a variety of infections. We will review the currently available antimicrobial agents and discuss the clinical data supporting the use of the various agents.
Related Papers
- → Antimicrobial Activity of Selected Antimicrobial Peptides Against Planktonic Culture and Biofilm of Acinetobacter baumannii(2018)60 cited
- → TheAcinetobacter baumanniigroup:a systemic review(2013)30 cited
- → Inhibition of Virulence Factors and Biofilm Formation ofAcinetobacter Baumanniiby Naturally-derived and Synthetic Drugs(2020)13 cited
- การศกษาฤทธของสารสกดสมนไพรในประเทศไทยในการตานเชอ Acinetobacter baumannii ทกอใหเกดโรคตดเชอในโรงพยาบาลสรรพสทธประสงค(2014)
- Inspection and analysis of antibiotic resistance of Acinetobacter baumannii(2012)